OpenAlex
PricingAboutJobs
Log inGet started
Work

The biological profile of PD 0325901: A second generation analog of CI-1040 with improved pharmaceutical potential

HTML

Year: 2004
Type: article
Source: Cancer Research
Authors: Judith S. Sebolt–Leopold, Ronald L. Merriman, Charles A. Omer, Haile Tecle, Alex J. Bridges, Wayne D. Klohs, Cho‐Ming Loi, Heather Valik, Sally Przybranowski, Mark B. Meyer, Wilbur R. Leopold
Institution: Pfizer (United States)
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PD0325901, CI-1040, MEK inhibitors, ERK1/2 phosphorylation, MEK inhibition, tumor xenografts, bioavailability, metabolic stability, anticancer activity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1606821595
FWCI: 0.193
Cites:
Cited by: 22
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security